Every open market buy and sale of Ionis Pharmaceuticals Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net sellers over the last 12 months: $1.2M bought and $118M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when IONS insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an IONS officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every IONS insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Michael R HaydenDirector | Buy | 5,000 | $29.64 | $148K | 27,000 | Nov 13Form 4 |
| Oct 16, 2026 | Eric SwayzeEVP Research | Sale | 53 | $43.54 | $2K | 390 | Oct 19Form 4 |
| Oct 16, 2026 | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 1,357 | $43.54 | $59K | 17,811 | Oct 19Form 4 |
| Jul 31, 2026 | Michael R HaydenDirector | Buy | 20,000 | $52.94 | $1.1M | 24,000 | Jul 31Form 4 |
| Jul 7, 2026 | Holly B. KordasiewiczEVP, Chief Development Officer | Sale plan | 362 | $84.30 | $31K | 22,096 | Jul 9Form 4 |
| Jul 7, 2026 | Allene M. DiazDirector | Sale plan | 10,111 | $85.42 | $864K | 3,811 | Jul 9Form 4 |
| Jul 7, 2026 | C Frank BennettEVP, Chief Scientific Officer | Sale plan | 20,536 | $84.95 | $1.7M | 0 | Jul 9Form 4 |
| Jul 1, 2026 | Joseph Klein IIIDirector | Sale plan | 11,518 | $79.04 | $910K | 11,014 | Jul 6Form 4 |
| Jun 26, 2026 | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale plan | 26,000 | $81.05 | $2.1M | 77,114 | Jun 30Form 4 |
| Jun 26, 2026 | Patrick R. O'neilEVP CLO & General Counsel | Sale plan | 3,069 | $80.00 | $246K | 61,470 | Jun 30Form 4 |
| Jun 26, 2026 | Joseph BaroldiEVP, Chief Business Officer | Sale plan | 5,635 | $80.16 | $452K | 4,669 | Jun 30Form 4 |
| Jun 26, 2026 | Brett P MoniaCEO | Sale plan | 85,637 | $79.70 | $6.8M | 245,571 | Jun 26Form 4 |
| Jun 25, 2026 | Eric SwayzeEVP Research | Sale plan | 10,602 | $79.18 | $839K | 21,759 | Jun 26Form 4 |
| Jun 15, 2026 | Spencer R BerthelsenDirector | Sale plan | 8,000 | $73.49 | $588K | 156,013 | Jun 16Form 4 |
| Jun 12, 2026 | Holly B. KordasiewiczEVP, Chief Development Officer | Sale plan | 60,846 | $73.41 | $4.5M | 22,458 | Jun 16Form 4 |
IONS insider trading FAQ
Are IONS insiders buying or selling?
Insiders are net sellers over the last 12 months. 1 insiders bought $1.2M of IONS on the open market in 2 trades, and 17 sold $118M in 64 trades, 84% of that under pre-arranged trading plans.
When did an IONS insider last buy shares?
Michael R Hayden (Director) bought 5,000 shares for $148K on Nov 10, 2026, reported on Nov 13, 2026.
When did an IONS insider last sell shares?
Eric Swayze (EVP Research) sold 53 shares for $2K on Oct 16, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
